◼ Archived
Business
AstraZeneca hopes to ‘achieve amazing things’ with new Kendall Square R&D center
1 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
4 trends tracked about this subject — the full history, oldest to newest below.
1 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
AstraZeneca asserts independence for post-2030 growth while investing over $1 billion in a new robotics-driven R&D hub in Cambridge, Massachusetts.
Takeda Pharmaceutical's R&D chief Andy Plump is set to retire in June 2027 following a period of significant pipeline reorganization and regulatory success.
GSK is launching a $2.5 billion cost-saving initiative to accelerate its late-stage drug pipeline and relocate its research headquarters.